[1]
“Conversion of Injectable Semaglutide into Oral Formulations: Comparative Evaluation of Tablet and Liquid Preparations for Pharmaceutical Feasibility and Biological Potential”, biolsciences, vol. 5, no. 4, pp. 1057–1060, Dec. 2025, doi: 10.55006/biolsciences.2025.5405.